ANA on the Frontline, ANA Annual Report
Learn about the top issues facing ANA member nurses, how ANA is working for you, and what ANA is doing to advance nursing. In…
Web Exclusives
How to be an online nurse influencer
Tips for building followers and expanding your healthcare impact Takeaways: Nurses can be influencers well beyond their immediate circle of patients, clients, and colleagues. …
Teach-back: An underutilized tool
In an effort to encourage nurses to use the teach-back method when educating patients, we conducted a literature review on the topic of patient…
Repetitive transcranial magnetic stimulation may improve memory
According to a study in PLoS ONE, repetitive transcranial magnetic stimulation improves memory. (more…)
Healthcare professionals’ implementation of EBP lagging
Although healthcare professionals’ self‐reported evidence-based practice (EBP) knowledge, skills, attitudes, and beliefs are at a moderate to high level, this doesn’t translate into EBP…
Prescription drugs in pregnant and nursing women
On May 8, the FDA released two draft guidance documents designed to improve understanding of effects of prescription drugs in pregnant and nursing women.…
FDA approves treatment for two rare diseases
On May 6, the FDA approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome in patients 6 to less than 17 years…
Healthcare professionals and medicinal cannabis
According to a systematic review in PLOSOne, healthcare professionals generally support the use of medicinal cannabis, but they lack knowledge and are concerned about…
ANA on the Frontline, May 2019
Learn about the top issues facing ANA member nurses, how ANA is working for you, and what ANA is doing to advance nursing. In…
May 2019 Vol. 14 No. 5
This issue includes two articles with so much information that we had to break them into two parts. The first is a feature titled…
FDA approves first treatment for pediatric patients with lupus
On April 26, the FDA approved Benlysta (belimumab) I.V. infusion for treatment of children with systemic lupus erythematosus (SLE). This is the first FDA-approved…
FDA approves treatment for hepatitis C in children
On April 30, the FDA approved Mavyret (glecaprevir and pibrentasvir) tablets to treat all six genotypes of hepatitis C virus (HCV) in children ages…
ANA on the Frontline, ANA Annual Report
Learn about the top issues facing ANA member nurses, how ANA is working for you, and what ANA is doing to advance…
How to be an online nurse influencer
Tips for building followers and expanding your healthcare impact Takeaways: Nurses can be influencers well beyond their immediate circle of patients, clients,…
Teach-back: An underutilized tool
In an effort to encourage nurses to use the teach-back method when educating patients, we conducted a literature review on the topic…
Repetitive transcranial magnetic stimulation may improve memory
According to a study in PLoS ONE, repetitive transcranial magnetic stimulation improves memory. (more…)
Healthcare professionals’ implementation of EBP lagging
Although healthcare professionals’ self‐reported evidence-based practice (EBP) knowledge, skills, attitudes, and beliefs are at a moderate to high level, this doesn’t translate…
Prescription drugs in pregnant and nursing women
On May 8, the FDA released two draft guidance documents designed to improve understanding of effects of prescription drugs in pregnant and…
FDA approves treatment for two rare diseases
On May 6, the FDA approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome in patients 6 to less than…
Healthcare professionals and medicinal cannabis
According to a systematic review in PLOSOne, healthcare professionals generally support the use of medicinal cannabis, but they lack knowledge and are…
ANA on the Frontline, May 2019
Learn about the top issues facing ANA member nurses, how ANA is working for you, and what ANA is doing to advance…
May 2019 Vol. 14 No. 5
This issue includes two articles with so much information that we had to break them into two parts. The first is a…
FDA approves first treatment for pediatric patients with lupus
On April 26, the FDA approved Benlysta (belimumab) I.V. infusion for treatment of children with systemic lupus erythematosus (SLE). This is the…
FDA approves treatment for hepatitis C in children
On April 30, the FDA approved Mavyret (glecaprevir and pibrentasvir) tablets to treat all six genotypes of hepatitis C virus (HCV) in…